Cargando…
Transcriptomics in Toxicogenomics, Part I: Experimental Design, Technologies, Publicly Available Data, and Regulatory Aspects
The starting point of successful hazard assessment is the generation of unbiased and trustworthy data. Conventional toxicity testing deals with extensive observations of phenotypic endpoints in vivo and complementing in vitro models. The increasing development of novel materials and chemical compoun...
Autores principales: | Kinaret, Pia Anneli Sofia, Serra, Angela, Federico, Antonio, Kohonen, Pekka, Nymark, Penny, Liampa, Irene, Ha, My Kieu, Choi, Jang-Sik, Jagiello, Karolina, Sanabria, Natasha, Melagraki, Georgia, Cattelani, Luca, Fratello, Michele, Sarimveis, Haralambos, Afantitis, Antreas, Yoon, Tae-Hyun, Gulumian, Mary, Grafström, Roland, Puzyn, Tomasz, Greco, Dario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221878/ https://www.ncbi.nlm.nih.gov/pubmed/32326418 http://dx.doi.org/10.3390/nano10040750 |
Ejemplares similares
-
Transcriptomics in Toxicogenomics, Part III: Data Modelling for Risk Assessment
por: Serra, Angela, et al.
Publicado: (2020) -
Transcriptomics in Toxicogenomics, Part II: Preprocessing and Differential Expression Analysis for High Quality Data
por: Federico, Antonio, et al.
Publicado: (2020) -
Read-across predictions of nanoparticle hazard endpoints: a mathematical optimization approach
por: Varsou, Dimitra-Danai, et al.
Publicado: (2019) -
Nextcast: A software suite to analyse and model toxicogenomics data
por: Serra, Angela, et al.
Publicado: (2022) -
Manually curated transcriptomics data collection for toxicogenomic assessment of engineered nanomaterials
por: Saarimäki, Laura Aliisa, et al.
Publicado: (2021)